MY-ATRIA is a multidisciplinary network which develops research and training “without walls” among academic, industrial and clinical entities in the area of atrial disease.

It will generate a new profile of Researcher with an intersectoral expertise able to fill the existing gap between basic research and clinical/business-oriented solutions.

MY-ATRIA brings together universities, companies and hospitals from 5 European countries (Italy, Spain, Sweden, Netherlands and Germany).

The aim of MY-ATRIA is to train a new figure of modern professional researchers in Atrial Fibrillation field with multidisciplinary competencies, able to transfer advances in basic science to market and clinics.
Three main research lines are investigated:

• Understanding atrial arrhythmia mechanisms: a better interpretation of atrial arrhythmias mechanisms will be obtained by studying the electrocardiogram (ECG), and intra-cavity atrial electrogram (EGM) using a hybrid in-silico/in-vivo methodology. Abnormal interatrial connections, normal and dilated left atrium, electrical remodelling, coupling, and fibrosis will be the target of this research activity.
• AF Monitoring, progression and risk stratification: a set of new tools will be developed to analyse and characterize the progression of paroxysmal AF suitable for implementation in wearable devices, to detect and monitor AF effectively in large populations for screening purposes. Moreover, multi-parametric AF detectors that include information from other available sensors (wristband, non-contact electrodes among others) will be developed.
• Studying the effects of treatment: by developing computational models and linking them to ECG and EGM. Electrocardiographic markers of the AF process will be assessed and linked to the treatment outcome in different patient categories and subtypes of AF including new-onset AF, structural heart disease.